CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CLD HEALTH OUTCOMES
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS)
NASH
CHOLESTATIC
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Embassy of Education CLDF Committees 2023 GI Fellow Board of Advisors
Embassy of Education
Webcasts & Podcasts Abstract Library Committee Members
 
HCV-Single Disease Content  
Webcasts
HCV   Educational Webcast
HCV Elimination Starts With You: A Call to Action for all Healthcare Providers   Educational Webcast
HBV, HCV, and HDV   Educational Webcast
Podcasts
HCV 101 - Confidently Treat HCV in any Setting   Educational Podcast
Slide Library
   Released: 2023
Webcast
HCV Elimination Starts With You: A Call to Action for All Healthcare Providers
43 slides
 
 
   Released: 2021
Webcast
Triple E for HCV: Engagement, Education and Eradication - ASAM
68 slides
 
 
   Released: 2020
Webcast
Triple E for HCV: Engagement, Education, and Eradication
70 slides
 
 
   Released: 2020
test
Hepatitis C: Screening, Barriers and Access to Therapy
28 slides
 
 
   Released: 2019
Webcast
AATOD Conference
159 slides
 
 
   Released: 2019
Webcast
Triple E for HCV Satellite Symposium - NCCHC
81 slides
 
 
   Released: 2019
Webcast
Hot Topics in Cirrhosis
120 slides
 
 
   Released: 2019
Webcast
Triple E for HCV Satellite Symposium - ASAM
75 slides
 
 
   Released: 2019
Webcast
Hepatology News Tonight Managing Complications of Cirrhosis
129 slides
 
 
   Released: 2018
test
HCV Advances 2018
51 slides
 
 
   Released: 2018
test
Hepatology News Tonight: Managing Complication of Cirrhosis
57 slides
 
 
   Released: 2018
Webcast
Hepatitis Elimination Symposium and Workshop
96 slides
 
 
   Released: 2017
Webcast
HCV Advances 2017
54 slides
 
 
   Released: 2017
Webcast
Expert Perspectives: Highlights on HCV from EASL 2017
61 slides
 
 
   Released: 2016
Webcast
Expert Perspectives: Best of HCV - 2016 Spring Update
82 slides
 
 
     
 
 
Abstract Library
1.Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals
 

Curr Opin Virol. 2024 Jun 25:67:101423. doi: 10.1016/j.coviro.2024.101423.Online ahead of print.

 

Felix Fiehn 1, Claudia Beisel 2, Marco Binder 3
 
2.Increased-risk versus standard-risk donation in lung transplantation: A United Network of Organ Sharing analysis
 

J Thorac Cardiovasc Surg. 2024 Jul;168(1):299-307.e3.doi: 10.1016/j.jtcvs.2023.08.053. Epub 2023 Sep 7.

 

Meredith Brown 1, Mohammed Abul Kashem 2, Huaqing Zhao 1, Hiromu Kehara 1, Roh Yanagida 1, Norihisa Shigemura 1, Yoshiya Toyoda 1
 
3.Direct-Acting Antiviral Agents in Prevention of Maternal-Fetal Transmission of Hepatitis C Virus in Pregnancy
 

Pathogens. 2024 Jun 16;13(6):508. doi: 10.3390/pathogens13060508.

 

Christopher Hartley 1, Trung Van 2, Wikrom Karnsakul 3
 
4.Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study
 

Int J Drug Policy. 2024 Jun 10:129:104477. doi: 10.1016/j.drugpo.2024.104477.Online ahead of print.

 

Alison D Marshall 1, Jake Rance 2, Gregory J Dore 3, Jason Grebely 3, Carla Treloar 2
 
5.Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee
 

Transpl Infect Dis. 2024 Jun 16:e14305. doi: 10.1111/tid.14305. Online ahead of print.

 

Helen S Te 1, Dong Heun Lee 2, Ann E Woolley 3, Maheen Z Abidi 4, Cynthia Fisher 5, Marty T Sellers 6, Sarah Taimur 7, Taylor Livelli 8, Tamika Watkins 8, Dzhuliyana Handarova 8, Gerald J Berry 9, Riki Graves 10, Chak-Sum Ho 11, Anna L Hughart 12, Michelle Kittleson 13, Charles C Marboe 14, Rachel A Miller 15, Tanvi S Sharma 16, Anil J Trindade 17, R Patrick Wood 18, Lorenzo N Zaffiri 19, Stephanie M Pouch 20, Lara Danziger-Isakov 21
 
6.Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study
 

J Med Internet Res. 2024 Jun 12:26:e53049. doi: 10.2196/53049.

 

Suzanne S Dickerson 1, Saliyah J George 2, Ana Ventuneac 3, Arpan Dharia 4, Andrew H Talal 4
 
7.How do we expand the lung donor pool?
 

Curr Opin Pulm Med. 2024 Jul 1;30(4):398-404.doi: 10.1097/MCP.0000000000001076. Epub 2024 Mar 28.

 

Bronwyn J Levvey 1, Gregory I Snell
 
8.Adherence in Hepatitis C Virus Treatment: What We Know
 

Semin Liver Dis. 2024 Jun 12. doi: 10.1055/a-2313-0111. Online ahead of print.

 

Steven L Flamm 1, Alessandra Mangia 2
 
9.Racial Disparities in Treatment and Outcomes of Patients With Hepatitis C Undergoing Elective Total Joint Arthroplasty
 

J Arthroplasty. 2024 Jul;39(7):1671-1678. doi: 10.1016/j.arth.2024.01.054. Epub 2024 Feb 6.

 

Cole M Howie 1, Kyle H Cichos 2, Mohamed G Shoreibah 1, Eric M Jordan 3, Kian R Niknam 4, Antonia F Chen 3, Erik N Hansen 4, Gerald G McGwin Jr 5, Elie S Ghanem 6
 
10.Imprinted immune abnormalities in liver transplant patients cured of hepatitis C with antiviral drugs
 

Liver Transpl. 2024 Jul 1;30(7):728-741. doi: 10.1097/LVT.0000000000000342.Epub 2024 Feb 6.

 

Erin H Doyle 1, Costica Aloman 2, Ahmed El-Shamy 1 3, Francis J Eng 1, Seunghee Kim-Schulze 4, Adeeb Rahman 4, Thomas Schiano 1, Peter Heeger 5, Andrea D Branch 1
 
11.EASL position paper on clinical follow-up after HCV cure
 

Thomas Reiberger 1, Sabela Lens 2, Giuseppe Cabibbo 3, Pierre Nahon 4, Anna Linda Zignego 5, Katja Deterding 6, Ahmed M Elsharkawy 7, Xavier Forns 8
 
12.Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?
 

World J Hepatol. 2024 May 27;16(5):661-666. doi: 10.4254/wjh.v16.i5.661.

 

Anna Maria Spera 1, Pasquale Pagliano 2, Valeria Conti 3
 
13.Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy
 

Infect Dis Poverty. 2024 May 28;13(1):39.doi: 10.1186/s40249-024-01200-9.

 

Nicola Coppola 1 2, Loredana Alessio 1 2 3, Stefania De Pascalis 1, Margherita Macera 1 2, Giovanni Di Caprio 2 4, Vincenzo Messina 4, Lorenzo Onorato 1 2, Carmine Minichini 1, Maria Stanzione 1, Gianfranca Stornaiuolo 1, Mario Starace 1, Caterina Monari 1, Federica Calò 1 5, Caterina Sagnelli 1 6, Mariantonietta Pisaturo 7 8
 
14.The State of Hepatitis C Elimination from the Front Lines: A Qualitative Study of Provider-Perceived Gaps to Treatment Initiation
 

J Gen Intern Med. 2024 May 23. doi: 10.1007/s11606-024-08807-6. Online ahead of print.

 

Christopher J Gonzalez 1, Shashi N Kapadia 2, Jeff Niederdeppe 3, Arpan Dharia 4, Andrew H Talal 4, Audrey R Lloyd 5, Ricardo Franco 5, Stephane Labossiere 6, Martin F Shapiro 7, Elaine Wethington 8 9
 
15.Evaluation of a Project Integrating Financial Incentives into a Hepatitis C Testing and Treatment Model of Care at a Sexual Health Service in Cairns, Australia, 2020-2021
 

Viruses. 2024 May 17;16(5):800. doi: 10.3390/v16050800.

 

Joshua Dawe 1, Carla Gorton 2, Rhondda Lewis 2, Jacqueline A Richmond 1, Anna L Wilkinson 1 3 4, Alisa Pedrana 1 3, Mark Stoové 1 3 5, Joseph S Doyle 1 6, Darren Russell 2 7
 
16.Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development
 

Viruses. 2024 May 18;16(5):803. doi: 10.3390/v16050803.

 

Brian G Pierce 1 2, Nathaniel Felbinger 1 2, Matthew Metcalf 1 2, Eric A Toth 1, Gilad Ofek 1 2, Thomas R Fuerst 1 2
 
17.High prevalence of hepatitis C virus infection among incarcerated persons: Results from the Louisiana Hepatitis C Elimination Plan's opt-out testing program in prisons
 

J Viral Hepat. 2024 May 17. doi: 10.1111/jvh.13941. Online ahead of print.

 

Risha Irvin 1, Gia Landry 2 3, Miranda R Jones 4, Anthony James 3, Jean Schexnayder 3, Stacye Rodriguez 5, Deborah Wendell 3 6, Kathryn Barthe 3, Elizabeth Britton 3, Kendra LeSar 3, Sean Manogue 1, Olivia K Sugarman 4, Cynthia Brown 3, Samuel Burgess 3, Shruti H Mehta 4, David L Thomas 1, William Robinson 3 6; Louisiana Hepatitis C Elimination Plan Team
 
18.Screening for hepatitis C virus at the time of mammography using rapid diagnostic tests in women aged between 50 and 74 years (Mamm'OC NCT05067374)
 

J Viral Hepat. 2024 May 15. doi: 10.1111/jvh.13947. Online ahead of print.

 

Magdalena Meszaros 1 2, Séverine Coursier 2, Nicolas Nagot 3 4, Lionel Moulis 3 4, Patrice Taourel 4 5, Emma Pages-Bouic 5, Nathalie Fabre-Demard 6, Muriel Trentini 7, Georges-Philippe Pageaux 1 4, Helene Donnadieu 2 4
 
19.Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs
 

J Viral Hepat. 2024 Jun;31(6):342-356. doi: 10.1111/jvh.13927. Epub 2024 Mar 3.

 

Mark S Sulkowski 1, Anthony Martinez 2, Gia L Tyson 3, Kathleen Scholz 4, Ricardo A Franco 5, Anita Kohli 6, Susan F Julius 7, Paulina Deming 8, Scott A Fink 9, Keisa Lynch 10, Marina Roytman 11, Tuesdae R Stainbrook 12, Marshe D Turner 13, Matthew Viera-Briggs 14, Christian B Ramers 15 16 17
 
20.The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statement
 

Public Health. 2024 May 22:232:153-160. doi: 10.1016/j.puhe.2024.04.017. Online ahead of print.

 

C Cook 1, L Reid 2, A M Elsharkawy 3, A Radley 4, S Smith 5, S McPherson 6, D Crockford 7, J F Dillon 8, M Wright 9, D Morris 10, H Malik 11, S Keall 12, J Powell 13, J Catt 14, H Hampton 15, H Boothman 16, S Shah 17, J Spear 18, A Ustianoski 19, P John 20, H Stevens 21, S I Khakoo 22, J Parkes 23, R M Buchanan 24
 
21.Micro-elimination of chronic hepatitis C virus in mental health settings: A prospective multicentre pragmatic trial
 

Drug Alcohol Rev. 2024 May 21. doi: 10.1111/dar.13854. Online ahead of print.

 

Cameron Gofton 1 2 3, Kindness Bondezi 1, Beth Kotze 4, Kristen McKee 1, Antoni Yesudoss 5, Geoff McCaughan 6, Jacob George 1
 
22.Molecular Point-of-Care Testing for Hepatitis C: Available Technologies, Pipeline, and Promising Future Directions
 

J Infect Dis. 2024 May 8;229(Supplement_3):S342-S349.doi: 10.1093/infdis/jiad463.

 

Elena Ivanova Reipold 1, Sonjelle Shilton 1, Marco Donolato 1, Marta Fernandez Suarez 1
 
23.Tools Needed to Support Same-Day Diagnosis and Treatment of Current Hepatitis C Virus Infection
 

J Infect Dis. 2024 May 8;229(Supplement_3):S362-S369.doi: 10.1093/infdis/jiad177.

 

Gregory P Fricker 1, Marc G Ghany 2, Jorge Mera 3 4, Benjamin A Pinsky 5 6, John W Ward 7, Raymond T Chung 1 8 9
 
24.Metformin as adjuvant treatment in hepatitis C virus infections and associated complications
 

Am J Med Sci. 2024 May 1:S0002-9629(24)01213-8.doi: 10.1016/j.amjms.2024.04.019. Online ahead of print.

 

Dylan Landis 1, Alex Sutter 1, Sachi Khemka 1, Busara Songtanin 1, Jacob Nichols 1, Kenneth Nugent 2
 
25.The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination
 

Clin Infect Dis. 2024 May 15;78(5):1235-1239. doi: 10.1093/cid/ciad503.

 

Shashi N Kapadia 1, Ashly E Jordan 2, Benjamin J Eckhardt 3, David C Perlman 2 4
 
View More
 
 

HEPATITIS

HBV
HCV
HDV

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

NASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

PBC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2024 GI Fellow Board of Advisors

Other Resources

Journal Abstracts

Subscribe

Be the first to know about our latest upcoming programs and events!
CLDF

Follow us
Facebook
Twitter
Youtube
LiverQ
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2024 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.